You are here

Bayer

Regeneron, Bayer's Eylea nabs six months of pediatric exclusivity as competition waits to enter the market

Endpoints

Mon, 10/24/22 - 11:10 pm

pediatric exclusivity

Tavros signs $930M biobucks deal with Bayer's Vividion in hunt for 4 oncology targets

Fierce Biotech

Wed, 10/12/22 - 10:30 am

Vividion Therapeutics

Tavros Therapeutics

Bayer, Hua Medicine snag first-in-class nod in China for Roche castoff diabetes drug

Fierce Pharma

Mon, 10/10/22 - 10:57 am

Bayer’s Teach Me How to Gummy TikTok targets older audience

Medical Marketing and Media

Tue, 10/4/22 - 10:56 am

DTC advertising

Bayer highlights oncology ambitions in new Kendall Square labs

Endpoints

Thu, 09/15/22 - 10:21 am

Bayer's hunt for a new CEO is on, suggesting Werner Baumann could be headed for an early exit: report

Fierce Pharma

Tue, 09/13/22 - 07:59 pm

Bayer Launches Sustainable Packaging Innovation Challenge

Medical Devices and Diagnostics Industry

Sun, 09/11/22 - 11:00 pm

Bayer, Regeneron's eye drug shown to work at higher dose, longer intervals

Yahoo/Reuters

Thu, 09/8/22 - 04:33 pm

diabetic macular edema

wet age-related macular degeneration

Bayer pays $40M to settle with whistleblower who said company violated False Claims Act

Fierce Pharma

Tue, 09/6/22 - 05:15 pm

False Claims Act

whistleblower lawsuits

Bayer’s BlueRock inks cardiovascular cell therapy delivery deal

Fierce Pharma

Wed, 08/31/22 - 10:22 am

BlueRock Therapeutics

Positive data on Kerendia in chronic kidney disease and type 2 diabetes

Pharma Letter

Mon, 08/29/22 - 10:38 am

chronic kidney disease

Bayer gets FDA nod to extend use of popular contraceptive IUD Mirena

Endpoints

Sun, 08/28/22 - 10:08 pm

Revealed: which pharma companies leading the way in artificial intelligence

Clinical Trials Arena

Fri, 08/26/22 - 10:37 am

artificial intelligence

Johnson & Johnson

Bristol Myers Squibb

Merck, seeking XI factor in race with Bayer, gets FDA fast-track tag for anticoagulant

Fierce Biotech

Tue, 08/23/22 - 10:32 am

end-stage renal disease

ESC 2022 preview – who’s got the XI factor?

EP Vantage

Tue, 08/23/22 - 10:23 am

Bristol Myers Squibb

Bayer gets FDA nod to extend use of popular contraceptive IUD Mirena

Endpoints

Thu, 08/18/22 - 11:16 pm

After Roe ruling, Bayer enlists lobbyists to fight for contraceptive access

Fierce Pharma

Thu, 08/11/22 - 11:26 pm

Kodiak matches Regeneron’s Eylea in macular edema phase 3, lighting Beacon of hope after flop

Fierce Biotech

Tue, 08/9/22 - 06:34 am

Kodiak Sciences

clinical trials

Merck plans to count coughs and months until gefapixant is back in FDA hands

Fierce Biotech

Fri, 08/5/22 - 10:54 am

Bayer CEO Werner Baumann says company is 'putting major litigation behind us' while highlighting Q2 growth

Endpoints

Thu, 08/4/22 - 06:15 pm

Pages